Pages that link to "Q31388660"

The following pages link to Platelet activation in depression and effects of sertraline treatment: An open-label study (Q31388660):

Displaying 45 items.

• Influence of antidepressants on hemostasis (Q24635625) (← links)
• Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation? (Q26750898) (← links)
• Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks (Q28219114) (← links)
• Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction (Q28345555) (← links)
• 2D-DIGE proteome analysis on the platelet proteins of patients with major depression (Q30009505) (← links)
• Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? (Q31102771) (← links)
• Depression in patients with heart disease: the case for more trials (Q34080316) (← links)
• Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients (Q34182611) (← links)
• Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients (Q34384552) (← links)
• Depression and heart disease: evidence of a link, and its therapeutic implications (Q34515234) (← links)
• Broken heart: depression in cardiovascular disease (Q35236309) (← links)
• Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link? (Q35542747) (← links)
• Responses of mental stress–induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial (Q35662050) (← links)
• Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? (Q35772824) (← links)
• Global Metabolomic Profiling of Mice Brains following Experimental Infection with the Cyst-Forming Toxoplasma gondii (Q35796975) (← links)
• Physiological correlates of bereavement and the impact of bereavement interventions (Q36062190) (← links)
• Pharmacologic treatment of depression in patients with myocardial infarction (Q36077310) (← links)
• Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions. (Q36115552) (← links)
• Increased mean platelet volume in patients with panic disorder (Q36176741) (← links)
• Identification of hypertensive patients with dominant affective temperaments might improve the psychopathological and cardiovascular risk stratification: a pilot, case-control study (Q36217733) (← links)
• Antidepressants and risk of upper gastrointestinal bleeding (Q36447534) (← links)
• Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors (Q36656441) (← links)
• Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues (Q36914846) (← links)
• A review of etiologies of depression in COPD. (Q37082587) (← links)
• Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality (Q37089567) (← links)
• Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD). (Q37171411) (← links)
• Platelets and depression in cardiovascular disease: A brief review of the current literature (Q37195327) (← links)
• Psychological distress and cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). (Q37511304) (← links)
• Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome? (Q37732309) (← links)
• Epidemiology of Depression in Heart Failure (Q37812470) (← links)
• Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review (Q38219811) (← links)
• The platelet window: examining receptor regulated second messenger processes in psychosis and depression (Q38777353) (← links)
• Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature (Q38967657) (← links)
• Association of mean Platelet volume with DSM-IV major depression in a large community-based population: The MELEN study (Q39677341) (← links)
• Elevation in plasma Abeta42 in geriatric depression: a pilot study (Q40337244) (← links)
• Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment (Q40641442) (← links)
• Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide (Q44550796) (← links)
• Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding (Q46740740) (← links)
• Evaluation of peripheral serotonin content and α2-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements (Q47584940) (← links)
• Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression? (Q48327747) (← links)
• Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important (Q48797715) (← links)
• Increased platelet aggregability in major depression? (Q51965353) (← links)
• Platelet surface glycoprotein expression in post-stroke depression: a preliminary study (Q60655792) (← links)
• Changes in mean platelet volume and hematologic indices in patients with panic disorder due to oxidative stress (Q89876805) (← links)
• Is there a relationship between morphological and functional platelet changes and depressive disorder? (Q100944049) (← links)